littl
differ
sensit
specif
two
assay
sarkkinen
et
al
advantag
enzym
label
radioact
one
mainli
conveni
use
label
immunoreag
stabl
long
period
precaut
dispos
procedur
requir
radioisotop
unnecessari
addit
use
chromogen
substrat
enzym
label
permit
visual
interpret
test
result
case
real
disadvantag
eia
test
loss
antibodi
reactiv
may
result
conjug
enzym
limit
substrat
detect
exampl
use
enzym
molecular
weight
higher
igg
molecul
pdgalactosidas
mw
da
caus
steric
hindranc
antibodi
activ
herrmann
mors
regard
limit
substrat
detect
improv
enzym
detect
use
fluorogen
luminesc
radioact
substrat
review
yolken
propos
gener
principl
eia
test
detail
earlier
studi
review
number
time
yolken
hildebrand
voller
et
al
repeat
detail
rather
major
emphasi
current
develop
eia
methodolog
applic
eia
diagnosi
infecti
diseas
includ
test
antigen
antibodi
detect
viral
rickettsi
bacteri
mycot
infect
eia
test
diagnosi
parasit
agent
hormon
antigen
describ
discuss
solidphas
heterogen
eia
requir
immobil
antigen
antibodi
solid
surfac
mean
separ
antigenantibodi
complex
solidphas
surfac
use
immobil
antigen
antibodi
applic
polystyren
bead
tube
well
microtit
plate
well
polyvinyl
chlorid
microtit
plate
coupl
protein
surfac
usual
done
passiv
adsorpt
recent
adsorpt
antigen
antibodi
nitrocellulos
membran
adapt
detect
virus
eia
bode
et
al
coval
linkag
antibodi
antigen
varieti
surfac
includ
porou
glass
lynn
nylon
hendri
herrmann
cellulos
ferrua
et
al
agaros
streefkerk
deelder
polyacrylamid
avramea
guilbert
describ
major
solidphas
eia
test
found
clinic
detect
microbi
antigen
antibodi
use
util
plastic
microtit
plate
bead
antigen
antibodi
passiv
adsorb
solid
phase
situat
given
antigen
readili
attach
antibodi
antigen
appli
first
antigen
nonspecif
adsorb
polyllysin
use
enhanc
antigen
adsorpt
clq
compon
complement
captur
antigenantibodi
complex
yolken
assay
describ
noncompetit
type
although
number
competit
assay
describ
disadvantag
mani
competit
assay
antigen
detect
use
label
antigen
usual
difficult
prepar
label
antibodi
advent
monoclon
antibodi
competit
assay
specif
antibodi
becom
common
number
differ
format
eia
test
antigen
antibodi
possibl
discuss
section
ii
c
avoid
need
separ
antigenantibodi
complex
homogen
eia
test
develop
rubinstein
et
al
homogen
assay
base
reaction
antigen
antibodyenzym
complex
result
steric
hindranc
enzym
caus
decreas
product
reaction
enzym
substrat
major
advantag
homogen
assay
requir
separ
wash
step
requir
heterogen
assay
major
disadvantag
type
eia
difficult
appli
detect
highmolecularweight
antigen
degre
sensit
requir
thu
homogen
assay
use
mainli
detect
hormon
drug
lowmolecularweight
substanc
mean
improv
sensit
homogen
assay
devis
review
yolken
wide
use
thu
applic
discuss
limit
eia
test
solidphas
type
enzym
immunoassay
antibodi
microbi
agent
util
almost
common
infecti
diseas
sensit
requir
well
within
rang
eia
summari
procedur
often
use
given
tabl
choic
assay
depend
sensit
requir
avail
reagent
whether
classspecif
test
desir
detect
igm
either
noncompetit
eia
class
captur
method
use
noncompetit
eia
enzymelabel
antiglobulin
step
specif
igm
use
advantag
igm
captur
indirect
test
enzymelabel
rrlin
ad
enzym
substrat
ad
substrat
hydrolysi
product
proport
amount
igm
present
method
less
problem
sera
contain
rheumatoid
factor
rf
although
precaut
must
taken
design
test
avoid
weakli
reactiv
sera
contain
rf
parri
briantai
et
al
use
enzymelabel
antigen
test
igm
use
diagnosi
number
viral
infect
eg
cytomegaloviru
schmitz
et
al
epsteinbarr
viru
schmitz
flavivirus
schmitz
emmerich
requir
purifi
antigen
label
thu
limit
agent
product
purif
antigen
rel
simpl
offer
improv
diagnosi
well
major
classspecif
eia
test
igm
sometim
refer
macelisa
antibodi
captureelisa
igm
import
serolog
marker
indic
recent
infect
singl
serum
specimen
avail
howev
substitut
classspecif
marker
use
method
detect
antigen
eia
done
competit
noncompetit
format
assay
antibodi
lower
limit
sensit
detect
antigen
eia
studi
approxim
pg
ng
although
lower
limit
describ
kato
et
al
level
sensit
suffici
detect
virtual
culturepropag
infecti
agent
alway
sensit
enough
detect
antigen
directli
clinic
specimen
type
format
often
use
shown
tabl
number
factor
determin
haw
effici
assay
detect
antigen
antibodi
inher
control
eg
amount
antigen
usual
present
posit
clinic
specimen
other
test
design
control
import
variabl
control
discuss
eia
format
requir
coval
coupl
enzym
antibodi
antigen
number
enzym
coupl
techniqu
tri
review
yolken
consist
result
obtain
horseradish
peroxidas
coupl
use
period
nakan
kawaoi
alkalin
phosphatas
coupl
use
glutaraldehyd
avramea
assay
found
clinic
use
diagnos
infecti
diseas
use
chromogen
substrat
although
fluorogen
radioact
substrat
describ
yolken
avramea
guesdon
luminesc
one
review
seitz
recent
develop
eia
found
applic
diagnost
microbiolog
use
avidin
biotin
guesdon
et
al
test
base
high
affin
constant
bind
biotin
avidin
common
method
use
specif
antibodi
label
biotin
indic
system
enzymelabel
avidin
recent
adapt
method
use
biotinil
betalactamas
combin
avidin
effect
detect
rotaviru
antigen
yolken
wee
addit
antibodi
affin
sensit
indic
system
use
sensit
mani
antigen
detect
system
depend
amount
antibodi
immobil
effect
solid
phase
method
immobil
antibodi
plastic
surfac
usual
base
simpl
adsorpt
although
convalentlink
method
util
amount
immunoglobulin
immobil
variou
plastic
given
tabl
herrmann
increas
amount
antibodi
bound
solidphas
surfac
result
increas
sensit
eia
howev
note
increas
concentr
antibodi
coat
surfac
beyond
kgml
give
increas
immunoassay
sensit
appar
due
desorpt
antibodi
plastic
surfac
steric
hindranc
antibodi
adsorb
solidphas
surfac
plastic
tube
bead
particl
porou
glass
lynn
use
immobil
antibodi
howev
major
eia
test
microbi
infect
use
either
plastic
plate
bead
recent
develop
mention
may
applic
varieti
microbi
antigen
antibodi
use
nitrocellulos
membran
disk
solid
phase
success
develop
visual
readout
method
detect
adenoviru
antigen
antibodi
bode
et
al
use
antibodi
highli
specif
high
affin
critic
aspect
eia
techniqu
exampl
reagent
use
determin
eia
effect
shown
two
paper
discuss
detect
clostridium
dz
nle
toxin
sensit
increas
chang
immunoreag
use
laughon
et
al
diluent
use
antigen
prepar
also
alter
sensit
disrupt
microbi
agent
deterg
chemic
may
increas
sensit
assay
decreas
other
yolken
number
diluent
usual
use
eia
test
test
conroy
esen
adsorb
plant
protein
polystyren
includ
deterg
acid
alcohol
urea
use
alcohol
urea
increas
eia
substanti
whether
would
applic
microbi
antigen
remain
test
diagnosi
infecti
diseas
accomplish
past
either
isol
infecti
agent
measur
serolog
convers
given
agent
serolog
convers
measur
high
level
igm
increas
total
antibodi
convalesc
sera
compar
acut
sera
use
eia
extens
previous
use
serolog
test
use
enzyinelabel
antibodi
antigen
determin
antibodi
content
direct
detect
antigen
eia
repres
dramat
departur
previou
method
base
cultur
also
method
enabl
detect
infecti
agent
difficult
cultiv
hepat
viru
rotaviru
agent
cultiv
hepat
b
viru
section
v
summari
bacteri
mycot
infect
eia
serolog
test
devis
given
tabl
iva
report
variou
degre
sensit
specif
review
hill
matsen
sensit
greater
report
assay
hut
sensit
low
mani
other
thu
test
must
care
examin
determin
use
specif
infect
addit
problem
low
sensit
major
drawback
mani
assay
lack
standard
without
avail
standard
serum
sampl
evalu
assay
new
assay
requir
test
number
investig
valid
assess
mani
instanc
howev
serolog
diagnosi
mean
avail
mani
laboratori
diagnos
exot
diseas
exampl
diagnosi
lyme
diseas
cultur
ofth
caus
spirochet
possibl
often
ineffect
use
eia
test
specif
igm
igg
respons
patient
proven
lyin
diseas
diagnost
eia
gave
fals
posit
result
control
subject
craft
et
ae
earli
recognit
diseas
anoth
area
eia
test
specif
igm
igg
may
best
method
avail
diagnosi
tubercul
mening
hernandez
et
al
although
new
dittmar
et
al
hopkin
et
al
mathiesen
et
al
feinston
et
al
gilman
docherti
leinikki
passila
monath
et
al
hofmann
et
al
forghani
et
al
er
develop
use
latex
particl
agglutin
diagnosi
diseas
may
prove
use
serolog
krambov
et
al
applic
antibodi
eia
diagnosi
viral
infect
given
tabl
v
b
discuss
bacteri
mycot
infect
serolog
diagnosi
eia
agent
list
still
larg
experiment
frequent
use
applic
screen
immun
statu
rubella
test
cytomegaloviru
antibodi
antibodi
hepat
b
antigen
serolog
diagnosi
infecti
mononucleosi
also
method
choic
heterophil
antibodi
test
use
specif
epsteinbarr
viru
test
usual
done
agglutin
eia
test
may
sensit
halbert
specif
eia
test
antibodi
epsteinbarr
viru
compon
also
describ
hopkin
et
al
yet
wide
use
mani
virus
difficult
isol
nt
yet
cultiv
serolog
test
often
use
diagnosi
use
igm
captur
eia
determin
recent
viral
infect
becom
common
may
provid
aid
diagnosi
antigen
detect
method
avail
use
eia
test
detect
microbi
antigen
provid
altern
cultur
mean
direct
identif
specif
microbi
agent
also
provid
mean
detect
microbi
agent
success
propag
detect
circul
antigen
detect
antigen
bodi
fluid
eia
difficult
detect
antibodi
sensit
requir
interf
substanc
specimen
fece
respiratori
secret
reason
antigen
detect
assay
sensit
specif
requir
use
primari
diagnost
test
number
test
develop
howev
impress
possibl
rapid
specif
diagnosi
interest
antigen
detect
eia
remain
high
test
develop
bacteri
infect
primarili
diseas
caus
agent
difficult
cultur
rapid
diagnosi
permit
prompt
treatment
note
compar
tabl
iv
v
far
fewer
eia
antigen
detect
test
antibodi
test
reason
cite
effici
assay
report
variabl
none
sensit
correspond
cultur
techniqu
one
test
commerci
avail
write
eia
detect
neisseria
gonorrhoea
antigen
eia
evalu
anumb
laboratori
tabl
v
gener
almost
report
found
eia
equival
cultur
detect
gonorrhoea
male
femal
sensit
rang
papasian
et
al
danielson
et
al
specif
mani
et
al
danielson
et
al
two
extens
studi
report
specif
stamm
et
al
demetri
et
al
thu
reliabl
eia
appear
depend
effici
cultur
method
use
perhap
variabl
perform
test
eia
test
also
develop
anoth
agent
sexual
transmit
diseas
chlamydia
trachomuti
agent
difficult
cultiv
n
gonorrhoea
cell
cultur
requir
one
eia
william
et
al
khan
segal
et
al
torsch
pronovost
et
al
mathiesen
et
al
wolter
et
al
miranda
et
al
grillner
landqvist
land
et
al
lawrenc
et
al
morgan
smith
nerukar
et
warford
et
al
berg
et
al
harmon
et
al
sarkkinen
et
al
yolken
et
al
sarkkinen
et
al
ziegler
examin
signific
number
sampl
commerci
produc
test
develop
chlamydiazym
abbott
laboratori
premarket
evalu
test
patient
show
eia
sensit
specif
jone
et
larger
studi
involv
specimen
eia
sensit
specif
mycoplasma
homini
may
also
involv
sexual
transmit
diseas
diagnosi
cultur
requir
expertis
antigen
eia
develop
miettinen
et
al
posit
six
specimen
posit
cultur
extens
evalu
requir
determin
util
assay
screen
procedur
detect
eia
bacteri
antigen
cerebrospin
fluid
csf
respiratori
tract
secret
also
attempt
good
result
antigen
yolken
et
al
report
sensit
detect
pneumococc
antigen
csf
specimen
other
found
difficulti
differenti
pneumococc
antigen
meningococc
antigen
csf
eia
use
monoclon
antibodi
detect
group
meningococc
antigen
describ
sugasawara
et
al
sensit
polyclon
serum
detect
antigen
csf
sampl
detect
haemophil
influenza
b
eia
shown
effect
limit
clinic
trial
drow
et
al
develop
eia
sensit
posit
csf
sampl
use
similar
eia
system
detect
sampl
posit
haemophilu
counterimmunoelectrophoresi
coagul
posit
cultur
antigen
detect
eia
respiratori
infect
describ
legionella
pneumophila
tuberculosi
streptococcu
group
infect
extens
studi
detect
l
pneumophila
antigen
urin
done
sathapatayavong
et
al
obtain
sensit
specif
urin
patient
diseas
inhibit
eia
detect
streptococcu
group
antigen
throat
swab
also
effect
give
sensit
specif
knigg
et
al
confirm
diagnosi
tuberculosi
difficult
long
period
requir
cultur
caus
organ
preliminari
result
eia
develop
sada
et
al
util
rabbit
antibodi
bcg
show
sensit
sampl
patient
tuberculosi
mening
antibodi
bgg
may
cross
react
mycobacteria
well
speci
nocardia
corynebacterium
test
need
evalu
specif
also
eia
test
develop
detect
bacteri
toxin
clinic
sampl
notabl
assay
clostridium
dijjficil
toxin
lyerli
et
al
develop
eia
c
di
fficiz
toxin
specif
sampl
sensit
improv
assay
john
e
herrmann
toxin
b
toxin
report
laughon
et
al
tissuecultureposit
specimen
posit
toxin
posit
toxin
b
combin
posit
either
b
toxin
thu
one
eia
test
appear
mark
improv
difficult
tissu
cultur
toxin
assay
detect
eia
stool
toxin
clostridium
speci
c
perfringen
mcclane
strous
c
botulinum
b
dezfulian
et
al
also
report
two
unrel
infect
diagnos
antigen
eia
bacteroid
fragili
yersinia
pesti
infect
test
b
fragili
urin
specif
detect
antigen
individu
shown
infect
b
fragili
riss
et
al
use
monoclon
antibodi
antigen
pesti
insensit
eia
detect
antigen
sera
patient
acut
bubon
plagu
william
et
al
antivir
agent
becom
avail
respiratori
viru
infect
rapid
method
diagnosi
essenti
prompt
treatment
rapid
diagnosi
eia
propos
number
respiratori
virus
sever
describ
diagnosi
respiratori
syncyti
viru
specif
appear
problem
eia
report
sensit
less
found
cultur
compar
cultur
sensit
found
chao
et
al
hornsleth
et
al
hornsleth
et
al
mcintosh
et
al
diagnosi
viral
influenza
eia
also
report
variabl
result
compar
cultur
harmon
pawlik
report
sensit
later
report
harmon
et
al
eia
use
fluorogen
substrat
gave
sensit
use
radioact
substrat
coonrod
et
al
abl
detect
influenza
viru
nasal
wash
maximum
sensit
given
day
infect
similar
assay
describ
yolken
sampl
volunt
gave
sensit
loo
depend
day
test
test
adenoviru
respiratori
secret
also
develop
harmon
pawlik
compar
eia
tissu
cultur
isol
abl
detect
eia
adenovirusposit
specimen
interest
sexual
transmit
herpesviru
avail
treatment
led
develop
number
eia
test
rapid
diagnosi
herp
infect
lack
suffici
sensit
use
substitut
cultur
two
evalu
commerci
eia
herp
genit
infect
ortho
diagnost
system
inc
report
morgan
smith
two
import
gastroenter
viral
agent
eia
test
develop
rotaviru
enter
adenovirus
eia
test
rotaviru
first
develop
yolken
et
al
commerci
assay
avail
recent
evalu
two
commerci
product
rotazym
abbott
laboratori
enzygnost
behr
show
sensit
rotazym
enzygnost
morinet
et
al
standard
comparison
electron
microscopi
em
eia
method
appear
suitabl
use
em
avail
although
rotazym
known
caus
fals
posit
result
sampl
neonat
chrysti
et
al
insensit
sampl
adult
herrmann
et
al
enter
adenovirus
type
difficult
isol
therefor
eia
method
would
prefer
sensit
satisfactori
preliminari
result
johansson
et
al
suggest
develop
eia
specif
enter
adenovirus
possibl
use
monoclon
antibodi
eia
test
offer
two
potenti
advantag
improv
specif
due
natur
monoclon
antibodi
improv
sensit
allow
clearer
eia
cutoff
valu
sensit
could
also
increas
increas
amount
detector
antibodi
use
eia
howev
monoclon
antibodi
react
one
epitop
given
antigen
one
monoclon
antibodi
may
need
achiev
desir
sensit
practic
monoclon
antibodi
use
success
latex
agglutin
test
also
immunofluoresc
techniqu
nowinkski
et
al
use
eia
limit
date
number
describ
microbi
antigen
date
suggest
applic
clinic
diagnosi
increas
eia
test
develop
look
promis
eia
detect
adenoviru
group
antigen
stool
monoclon
antibodi
sensit
polyclon
one
sensit
detect
noncultivat
adenovirus
presum
enter
serotyp
stool
sampl
posit
em
monoclon
eia
posit
anderson
et
al
use
monoclon
antibodi
detect
eia
microbi
antigen
cerebrospin
fluid
csf
also
look
promis
comparison
polyclon
monoclon
eia
test
group
meningococc
antigen
csf
csf
specimen
posit
polyclon
eia
posit
monoclon
eia
sugasawara
et
al
preliminari
studi
csf
specimen
posit
group
b
streptococc
antigen
react
monoclon
eia
morrow
et
al
diagnosi
rotaviru
infect
found
monoclon
eia
sensit
specif
sampl
adult
neonat
well
young
children
herrmann
et
nl
possibl
due
high
affin
broad
group
specif
monoclon
antibodi
use
cukor
et
al
preliminari
result
monoclon
eia
diagnos
legionellosi
show
posit
correl
case
bibb
et
al
howev
preliminari
studi
use
monoclon
eia
diagnosi
bubon
plagu
posit
laughon
et
al
situat
sensit
low
use
polyclon
sera
control
eia
would
desir
would
help
determin
problem
monoclon
antibodi
amount
antigen
present
clinic
sampl
although
mani
current
eia
test
microbi
antigen
antibodi
realiz
potenti
reason
believ
situat
improv
detect
antibodi
major
problem
standard
reagent
eia
methodolog
improv
reagent
becom
commerci
avail
standard
method
select
varieti
procedur
avail
detect
antigen
offer
rapid
direct
mean
diagnos
microbi
infect
major
problem
lack
sensit
increas
sensit
polyclon
eia
test
use
concentr
immunoreag
sensit
enzym
substrat
often
result
loss
specif
report
avail
date
appear
use
appropri
monoclon
antibodi
may
solv
problem
sensit
detect
mani
infecti
agent
clinic
sampl
increas
number
monoclon
antibodi
avail
variu
microbi
antigen
expect
util
eia
detect
system
affin
monoclon
antibodi
increas
eia
test
may
suffici
sensit
anoth
approach
taken
rapid
diagnosi
use
nucleic
acid
probe
hybrid
techniqu
review
richman
et
al
date
probe
use
radioact
label
requir
day
assay
make
impract
clinic
laboratori
use
biotin
label
coupl
enzym
marker
may
improv
speed
assay
sensit
assay
richman
et
al
whether
techniqu
becom
use
practic
direct
detect
microorgan
clinic
specimen
remain
determin
